Back

Non-vitamin K antagonist oral anticoagulants (NOACs) – Limitations and new opportunities

16 April 2023 (14:30 - 14:45)
Organised by:
Congress Presentation Part of: The new frontier in oral anticoagulation: Factor XIa inhibitors Stroke Prevention EHRA Premium Access EHRA 2023

About the speaker

Photo
Professor Jan Steffel

Klinik Hirslanden, Zurich (Switzerland)

4 More presentations in this session

Presentation thumbnail
This programme is supported by Bayer Pharma AG in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor
Slides
Presentation thumbnail
Factor XI inhibition – are NOACs obsolete? Mechanistic and pharmacological insights
Doctor J. Weitz (Hamilton, CA)
Slides Video
Presentation thumbnail
Factor XI inhibition – the new paradigm for atrial fibrillation and stroke
Professor G. Lip (Liverpool, GB)
Slides Video
Presentation thumbnail
Factor XI inhibition – other indications: acute coronary syndrome, venous thromboembolism
Professor D. Capodanno (Catania, IT)
Slides Video

Access the full session

Session thumbnail
The new frontier in oral anticoagulation: Factor XIa inhibitors
Video

The Event

Event poster

EHRA 2023

16 April 2023 14:30 CET
You may be interested in
thumbnail
Congress Session
Practical insights for your atrial fibrillation patients
26 August 2023
thumbnail
Congress Presentation
One year after the 2021 EHRA practical guide on NOACs: main points and new aspects.
3 April 2022
thumbnail
Congress Presentation
Current dilemmas in anticoagulation for venous thromboembolism.
28 August 2022
thumbnail
Congress Presentation
It’s time to rethink stroke prevention
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources